4//SEC Filing
Vanston David Cecil 4
Accession 0001078782-20-001005
CIK 0000093314other
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 4:11 PM ET
Size
12.8 KB
Accession
0001078782-20-001005
Insider Transaction Report
Form 4
VOLITIONRX LTDVNRX
Vanston David Cecil
Chief Financial Officer
Transactions
- Gift
Stock Option (Right to Buy)
2020-12-22−50,000→ 0 totalExercise: $3.25From: 2020-02-11Exp: 2025-02-11→ Common Stock (50,000 underlying) - Gift
Stock Option (Right to Buy)
2020-12-22+50,000→ 50,000 total(indirect: By Daughter)Exercise: $3.25From: 2020-02-11Exp: 2025-02-11→ Common Stock (50,000 underlying) - Gift
Stock Option (Right to Buy)
2020-12-22+60,000→ 60,000 total(indirect: By Daughter)Exercise: $4.00From: 2019-01-23Exp: 2024-01-23→ Common Stock (60,000 underlying) - Gift
Stock Option (Right to Buy)
2020-12-22−60,000→ 0 totalExercise: $4.00From: 2019-01-23Exp: 2024-01-23→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]The option to purchase an aggregate of 60,000 shares of Common Stock of VolitionRx Limited (the "Issuer"), was granted to Mr. Vanston on January 23, 2018, under the Issuer's 2015 Stock Incentive Plan (the "2015 Plan"). The option was transferred as a gift by Mr. Vanston to his daughter on December 22, 2020. Mr. Vanston disclaims beneficial ownership of the shares held by his daughter.
- [F2]The option to purchase an aggregate of 50,000 shares of Common Stock of the Issuer was granted to Mr. Vanston on February 11, 2019 under the Issuer's 2015 Plan. The option was transferred as a gift by Mr. Vanston to his daughter on December 22, 2020. Mr. Vanston disclaims beneficial ownership of the shares held by his daughter.
Documents
Issuer
VOLITIONRX LTD
CIK 0000093314
Entity typeother
Related Parties
1- filerCIK 0001703012
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 4:11 PM ET
- Size
- 12.8 KB